Estimating Toxicity-related Biological Pathway Altering Doses for High-throughput Chemical Risk Assessment Publication Estimating Toxicity-related Biological Pathway Altering Doses for High-throughput Chemical Risk Assessment We describe a framework for estimating the human dose at which a chemical significantly alters…CertaraApril 18, 2011
Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-experienced and CCR5 Antagonist-naive Patients Publication Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-experienced and CCR5 Antagonist-naive Patients TBR-652 is a novel CCR5 antagonist with potent in vitro anti-HIV activity. The objective of…CertaraApril 12, 2011
In Silico Prediction of Efavirenz and Rifampicin Drug-drug Interaction Considering Weight and CYP2B6 Phenotype Publication In Silico Prediction of Efavirenz and Rifampicin Drug-drug Interaction Considering Weight and CYP2B6 Phenotype This study aimed to test whether a pharmacokinetic simulation model could extrapolate nonclinical drug data…CertaraApril 1, 2011
Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Publication Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Physicians committed to the care of elderly patients are challenged with the diagnosis of venous…CertaraApril 1, 2011
Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Publication Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Prediction of metabolic clearance in extreme individuals rather than the 'average human' is becoming an…CertaraMarch 24, 2011
Is a Monte Carlo Simulation an Exotic Drink? Knowledge Base Is a Monte Carlo Simulation an Exotic Drink? The term “Monte Carlo simulation” is often used in the modeling and simulation literature with…CertaraMarch 21, 2011
What is the Difference Between Individual and Population PK? Knowledge Base What is the Difference Between Individual and Population PK? Pharmacokinetic analysis is often broken into two areas … “PK” and “population PK”. Sometimes the…CertaraMarch 14, 2011
Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Publication Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Reaction phenotyping using recombinant human cytochromes P450 (P450) has great utility in early discovery. However,…CertaraMarch 1, 2011
Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 Publication Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 has previously been shown to be a potent and selective antagonist of the human neurokinin-1…CertaraMarch 1, 2011
Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Publication Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Current guidance issued by the US FDA to assess the impact of renal impairment on…CertaraMarch 1, 2011